SNYR - Total Utang marang Modal Synergy CHC

Logo perusahaan publik Synergy CHC Corp. (SNYR)

This chart of the total debt-to-equity ratio for Synergy CHC Corp (SNYR) reflects 0.00. This results from rising traffic acquisition costs in the DTC segment and declining customer loyalty. The business relies on developing niche wellness brands through web promotion, while outsourcing operational processes and logistics to third-party contractors to concentrate on identifying promising assets.

SNYR: Total Utang marang Modal Synergy CHC Corporation 24.10.2024 - 03.10.2026

Rincian analitis perusahaan Synergy CHC Corp

- rega lan prakiraan konsensus rega:
Bagan rega Synergy CHC Corp.|SNYR - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Synergy CHC|SNYR - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Synergy CHC|SNYR - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku synergychc.com|SNYR - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Synergy CHC Corp|SNYR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Synergy CHC Corp.|SNYR - Gunggung utang perusahaan|Utang marang nilai buku Synergy CHC|SNYR - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Synergy CHC|Indikator likuiditas cepet synergychc.com
- informasi bathi lan kelipatan valuasi:
SNYR - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Synergy CHC Corp
Barang utama Synergy CHC

For Synergy CHC Corp (SNYR), changes in the total debt-to-equity ratio reflect the balance between debt financing and equity, determining the holding's level of dependence on creditors. This metric measures total liabilities per unit of equity, allowing for an assessment of the extent to which investments in biotechnological R&D and retail digitalization rely on external loans, which is critical for the business's resilience to macroeconomic shocks.

Analisis pesaing Synergy CHC Corp

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|Koefisien Total Utang marang Modal Entera Bio Ltd (ENTX)|HYFT: Rasio Total Utang marang Ekuitas|Utang marang Modal ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Utang marang Ekuitas|Rasio Utang marang Ekuitas QNTM|FGEN (FibroGen) - Total Utang marang Modal|Utang marang Modal Telomir Pharmaceuticals Inc TELO|Utang marang Ekuitas Rani Therapeutics (RANI)|RLYB (rallybio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|Rasio Utang marang Modal pulmatrix.com|PTHL: Rasio Total Utang marang Ekuitas|Utang marang Modal Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc) - Rasio Total Utang marang Ekuitas|Impact BioMedical, Inc. - Rasio Kabeh Utang marang Dana Pribadi|TNFA (TNF Pharmaceuticals Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas cbdMD Corp (YCBD)|Total Utang marang Modal PRFX|CYTO (altamiratherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LIPO (Lipella)|OPTN - Rasio Total Utang marang Ekuitas|PIRS: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PROC (procapsgroup.com)|PTPI: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Qilian International Holding Group|Utang marang Ekuitas ACELYRIN, Inc.|Utang marang Modal TFF Pharmaceuticals, Inc TFFP